1. Home
  2. PFO vs SERA Comparison

PFO vs SERA Comparison

Compare PFO & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

HOLD

Current Price

$9.67

Market Cap

123.3M

Sector

Finance

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$2.68

Market Cap

107.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFO
SERA
Founded
1991
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.3M
107.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PFO
SERA
Price
$9.67
$2.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.8K
57.1K
Earning Date
01-01-0001
03-18-2026
Dividend Yield
6.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$95,000.00
Revenue This Year
N/A
$25.84
Revenue Next Year
N/A
$715.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.06
52 Week Low
$6.90
$1.37
52 Week High
$8.51
$6.58

Technical Indicators

Market Signals
Indicator
PFO
SERA
Relative Strength Index (RSI) 64.84 30.62
Support Level $9.64 $3.30
Resistance Level $9.63 $2.93
Average True Range (ATR) 0.06 0.19
MACD 0.01 -0.08
Stochastic Oscillator 85.71 3.54

Price Performance

Historical Comparison
PFO
SERA

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: